EN PL
WYTYCZNE
Toczeń rumieniowaty układowy
 
 
Więcej
Ukryj
 
Data publikacji online: 11-10-2016
 
 
Reumatologia 2016;(Aktualizacja zaleceń postępowania diagnostyczno-terapeutycznego w chorobach reumatycznych na podstawie rekomendacji EULAR/ACR 1):26-35
 
 
REFERENCJE (18)
1.
Majdan M. Toczeń rumieniowaty układowy. Reumatologia 2012; 50: 103-111.
 
2.
Petri M, Orbai AM, Alarcón GS, et al. Derivation and validation of the Systemic Lupus International Collaborating Clinics classification criteria for systemic lupus erythematosus. Arthritis Rheum 2012; 64: 2677-2686.
 
3.
Hahn BH, McMahon MA, Wilkinson A, et al. American College of Rheumatology guidelines for screening, treatment, and management of lupus nephritis. Arthritis Care Res 2012; 64: 797-808.
 
4.
Bertsias GK, Tektonidou M, Amoura Z, et al. Joint EULAR and ERA-EDTA recommendations for the management of adult and paediatric lupus nephritis. Ann Rheum Dis 2012; 71: 1771-1782.
 
5.
Bertsias G, Ioannidis JP, Boletis J, et al. EULAR recommendations for management of systemic lupus erythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics. Ann Rheum Dis 2008; 67: 195-205.
 
6.
Mosca M, Tani C, Aringer M, et al. European League Against Rheumatism recommendations for monitoring patients with systemic lupus erythematosus in clinical practice and in observational studies. Ann Rheum Dis 2010; 69: 1269-1274.
 
7.
Belmont HM. Treatment of systemic lupus erythematosus. 2013 update. Bull Hosp Joint Dis 2013; 71: 208-213.
 
8.
Wofsy D. Recent progress in conventional and biologic therapy for systemic lupus erythematosus. Ann Rheum Dis 2013; 72 suppl: 66-68.
 
9.
Hanly JG. Diagnosis and management of neuropsychiatric SLE. Nat Rev Rheum 2014; 10: 338-347.
 
10.
Duru N, van der Goes MC, Jacobs JW, et al. EULAR evidence-based and consensus-based recommendations on the management of medium to high-dose glucocorticoid therapy in rheumatic diseases. Ann Rheum Dis 2013; 72: 1905-1913.
 
11.
Jacobs JW, Bijlsma JW. Glucocorticoids in rheumatology: indications and routes of administration. Clin Exp Rheum 2011; 29: S81-S84.
 
12.
Van Vollenhoven RF, Mosca M, Bertsias G, et al. Treat-to-target in systemic lupus erythematosus: recommendations from an international task force. Ann Rheum Dis 2014; 73: 958-967.
 
13.
Doria A, Gatto M, Iaccarino L, Punzi L. Value and goals of treat-to-target in systemic lupus erythematosus: knowledge and foresight. Lupus 2015; 24: 507-515.
 
14.
Rahman A, Isenberg DA. Systemic lupus erythematosus. N Engl J Med 2008; 358: 929-939.
 
15.
Hochberg MC. Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 1997; 40: 1725-1734.
 
16.
Hahn BH. Management of systemic lupus erythematosus. In: Kelley’s Texbook of Rheumatology. Harris ED (ed.). 7th ed. Elsevier Saunders, Philadelphia 2005; 1225-1247.
 
17.
Weening JJ, D’Agati VD, Schwartz MM, et al. The classification of glomerulonephritis in systemic lupus erythematosus revised. Kidney Int 2004; 65: 521-530.
 
18.
Majdan M, Ostanek L, Olesińska M i wsp. Płodność, planowanie ciąży i farmakoterapia w okresie ciąży i karmienia piersią u chorych na toczeń rumieniowaty układowy. Reumatologia 2014; 52: 16-24.
 
Copyright: © Narodowy Instytut Geriatrii, Reumatologii i Rehabilitacji w Warszawie. This is an Open Access journal, all articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (https://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
eISSN:2084-9834
ISSN:0034-6233
Journals System - logo
Scroll to top